Too much hype? Little-known drugmaker Sam Chun Dang rides weight-loss drug boom

Sam Chun Dang Pharm has surged to become the new heavyweight of Korea’s Kosdaq, as investor enthusiasm builds around its next-generation drug pipeline, including oral insulin and a weight-loss pill. Shares closed at 1.16 million won ($770) on Thursday, up 3.86 percent that day, pushing its market capitalization to 27.16 trillion won. The stock earlier hit a record 1.19 million won, after closing above the 1 million won mark the previous day — the first such milestone for a Kosdaq-listed company

By The Korea Herald